Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Sichuan Kelun Pharmaceutical (002422 CH)
Watchlist
82
Analysis
Health Care
•
China
Sichuan Kelun Pharmaceutical Co., Ltd. manufactures pharmaceutical products. The Company's products include large infusion products, tablets, capsules, antibiotic injection, lyophilized powder for injection, and traditional Chinese medicine.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Sichuan Kelun Pharmaceutical
•
25 Sep 2024 08:55
Sichuan Kelun Pharmaceutical (002422.CH) - The Real Breakthrough Point in Valuation Is ADC Pipeline
Kelun's traditional businesses lack imagination, but Kelun-bio's ADC pipeline is a highlight. Valuation may not be high due to lost pricing power...
Xinyao (Criss) Wang
Follow
340 Views
Share
bullish
•
Shenyang Xingqi Pharmaceutical
•
28 Oct 2024 01:30
China Healthcare Weekly (Oct.27)-10th National VBP, Revenue Scale Is the Only Moat, Xingqi’s Outlook
10th national VBP will impact big pharma like Kelun/Fosun/CSPC.Revenue scale is the only moat for pharma company.Xingqi's 24Q3 results may be...
Xinyao (Criss) Wang
Follow
235 Views
Share
bullish
•
Shanghai Henlius Biotech
•
29 Sep 2024 16:02
China Healthcare Weekly (Sep29)- Henlius Privatization Update, NHSA Fee Control, Hansoh Is Exception
The approval process of Henlius' privatization is slow, but the deal will get up. Medical insurance fee control policies will continue. Different...
Xinyao (Criss) Wang
Follow
335 Views
Share
bullish
•
China Shipbuilding Industry Group Power
•
12 Sep 2024 05:12
CSI300 Index Rebalance Preview: Round-Trip Trade Tops US$6bn as ETF Creations Soar
There could be 17 changes in Dec resulting in a round-trip trade of over US$6bn. 22 stocks have over 3x ADV to trade. The potential adds have...
Brian Freitas
Follow
859 Views
Share
bearish
•
Kelun Biotech
•
09 Jul 2024 09:48
Kelun-Biotech IPO Lock-Up Expiry - Strong Performance Leaves Pre-IPO Investors with Large Gains
Kelun Biotech (KB) raised around US$170m in its IPO in July 2023, the lockup on its pre-IPO shareholders is set to expire soon.
Sumeet Singh
Follow
302 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.39.3
x